| Literature DB >> 22086264 |
Mariëlla I Withagen1, Mark E Vierhout, Guido H Mannaerts, Robin M van der Weiden.
Abstract
INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate short-term anatomic and functional outcomes and safety of laparoscopic sacrocolpopexy with bone anchor fixation.Entities:
Mesh:
Year: 2011 PMID: 22086264 PMCID: PMC3305870 DOI: 10.1007/s00192-011-1599-5
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Baseline characteristics
| Data available for number of patients |
| |
|---|---|---|
| Age | 49 | 66 (45–86) |
| Parity | 47 | 2 (0–6) |
| BMI | 29 | 24 (21–32) |
| Comorbidity | 49 | 5 (10%) |
| Previous surgerya | ||
| Abdominal hysterectomy | 49 | 18 (37%) |
| Vaginal hysterectomy | 49 | 27 (55%) |
| Anterior colporraphy | 49 | 28 (57%) |
| Anterior mesh procedure | 49 | 1 (2%) |
| Posterior colporrhaphy | 49 | 27 (55%) |
| One POP procedure | 49 | 28 (57%) |
| More than one POP procedure | 49 | 5 (10%) |
| Previous incontinence surgery | 49 | 9 (18%) |
| Overall POP-stage | 49 | |
| I | 2 (4%) | |
| II | 33 (67%) | |
| III | 14 (29%) | |
| IV | 0 (0%) | |
| Point C | 49 | −1 (−3 to 4) |
| Pain (lower abdomen/genital area) | 47 | 11 (23%) |
| Dyspareunia | 20 | 3 (15%) |
aMultiple surgeries possible
Peri- and post-operative data
| Data available for number of patients |
| |
|---|---|---|
| Sacrocolpopexy | 49 | 43 (88%) |
| Cervicopexy | 49 | 2 (4%) |
| Hysteropexy | 49 | 4 (8%) |
| Operating time (min) | 49 | 120 (60–240) |
| Blood loss (ml) | 49 | 50 (10–100) |
| Duration urinary catheter (days) | 49 | 1 (1) |
| Hospital stay (days) | 49 | 1 (0–5) |
| Complications (intra-operative) | ||
| Conversion laparotomy due to injury ileum | 49 | 1 (2%) |
| Complications at 6 months | ||
| Neurologic complaints caused by irritation left sacral plexus | 49 | 1 (2%) |
| Cumulative mesh exposure | 49 | 1 (2%) |
| Pain (lower abdomen/genital area) | 47 | 3 (6%) |
| De novo pain | 47 | 0 (0%) |
| Dyspareunia | 20 | 4 (20%) |
| De novo dyspareunia | 20 | 3 (15%) |
POP-Q measurements at baseline and 6 months post-surgery
| POP-Q point | Data available for number of patients | Baseline | 6 months |
| ||
|---|---|---|---|---|---|---|
| Median (range) | Mean (SD) | Median (range) | Mean (SD) | |||
| Aa | 49 | −2 (−3 to 1) | −1.3 (1.0) | −2 (−3 to 0) | −1.7 (0.7) | 0.007 |
| Ba | 49 | −2 (−3 to 3) | −0.9 (1.6) | −2 (−3 to 2) | −1.4 (1.2) | 0.003 |
| C | 49 | −1 (−3 to 4) | −0.1 (1.8) | −8 (−8 to −3) | −7.7 (0.9) | <0.001 |
| GH | 49 | 3 (2 to 5) | 3.0 (0.7) | 3 (2 to 5) | 3.0 (0.7) | 0.99 |
| PB | 49 | 3 (2 to 3) | 2.7 (0.5) | 3 (2 to 3) | 3.0 (0.5) | 0.16 |
| TVL | 49 | 8 (7 to 9) | 8.0 (0.2) | 8 (7 to 9) | 8.0 (0.2) | 0.99 |
| Ap | 49 | −2 (−3 to 2) | −1.4 (0.9) | −2 (−3 to 0) | −1.9 (0.5) | <0.001 |
| Bp | 49 | −1 (−3 to 2) | −0.9 (1.4) | −2 (−3 to 2) | −1.6 (0.9) | <0.001 |
| D | 4 | −2.5 (−4 to 0) | −2.3 (1.7) | −8 (−8 to −5) | −7.3 (1.5) | 0.07 |
Anatomic failure
| POP-stage | Anterior compartment | Apical compartment | Posterior compartment | Overall | ||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 6 months | Baseline | 6 months | Baseline | 6 months | Baseline | 6 months | |
| Stage 0 | 2 (4%) | 3 (6%) | 2 (4%) | 49 (100%)a | 1 (2%) | 3 (6%) | 0(0%) | 2 (4%) |
| Stage I | 25 (51%) | 31 (63%) | 9(19%) | 0 (0%) | 23 (47%) | 34 (69%) | 2 (4%) | 21 (43%) |
| Stage II | 17 (35%) | 12 (24%) | 30 (61%) | 0 (0%) | 21 (43%) | 11 (22%) | 33 (67%) | 22 (45%) |
| Stage III | 5 (10%) | 3 (6%) | 8 (16%) | 0 (0%) | 4 (8%) | 1 (2%) | 14 (29%) | 4 (8%) |
| Stage IV | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Failure | 15 (31%) | 1 (2%) | 12 (24%) | 26 (53%) | ||||
Data presented as numbers (%)
Failure = POP ≥ stage II or POP < stage II with repeat surgery
aIncluding one repeat sacrocolpopexy within 6 months
Change in POP-Q point Ba, C, and Bp 6 months post-surgery
| Ba | C | Bp | |
|---|---|---|---|
| Improvement | |||
| 1 cm | 9 (19%) | 10 (21%) | |
| 2 cm | 3 (6%) | 3 (6%) | |
| 3 cm | 4 (8%) | 8 (16%) | |
| 4 cm | 1 (2%) | ||
| 5 cm | 4 (8%) | ||
| 6 cm | 10 (20%) | ||
| 7 cm | 13 (27%) | ||
| 8 cm | 11 (23%) | ||
| 9 cm | 5 (10%) | ||
| 10 cm | 1 (2%) | ||
| 11 cm | 2 (4%) | ||
| 12 cm | 2 (4%) | ||
| No change | 28 (57%) | 0 | 27 (55%) |
| Deterioration | |||
| 1 cm | 2 (4%) | 0 | |
| 2 cm | 2 (4%) | 0 | 1 (2%) |
| Repeat surgery | 1 (2%) |
Effect of surgery on symptoms and health related quality of life scores
| Domain | Baseline | 6 months |
| Bother score in relation to POP stage at 6 months | ||
|---|---|---|---|---|---|---|
| POP stage 0 + I ( | POP stage II ( | POP stage III ( | ||||
| UDI | ||||||
| Genital prolapse | 67.8 (28.8) | 13.3 (24.5) | <0.001 | 10.3 (23.3) | 13.3 (24.5) | 33.3 (33.3) |
| OAB | 33.3 (25.7) | 17.3 (18.9) | <0.001 | 12.7 (14.2) | 16.1 (17.8) | 47.2 (22.9) |
| Incontinence | 15.6 (20.1) | 10.0 (16.8) | 0.09 | 7.9 (17.2) | 10.0 (16.6) | 20.8 (16.0) |
| Obstructive micturition | 33.0 (24.7) | 14.8 (21.3) | <0.001 | 11.9 (16.8) | 13.3 (20.7) | 44.4 (38.5) |
| Pain | 26.8 (25.2) | 15.2 (19.3) | 0.002 | 11.1 (16.1) | 18.3 (22.2) | 22.2 (19.2) |
| DDI | ||||||
| Constipation | 13.0 (19.5) | 12.4 (20.4) | 0.56 | 5.6 (13.3) | 17.5 (23.9) | 27.8 (25.5) |
| Obstructed defecation | 13.5 (14.4) | 7.7 (11.1) | 0.002 | 6.3 (12.3) | 7.9 (9.4) | 20.8 (5.9) |
| Pain | 6.7 (15.8) | 7.0 (15.5) | 0.84 | 4.8 (15.0) | 8.8 (16.1) | 11.1 (19.3) |
| Incontinence | 4.0 (11.2) | 4.5 (9.8) | 1.00 | 5.6 (12.2) | 2.5 (6.1) | 11.1 (9.6) |
| IIQ | ||||||
| Physical functioning | 19.8 (26.3) | 13.6 (23.4) | 0.14 | 15.0 (23.5) | 11.4 (24.9) | 16.7 (19.3) |
| Mobility | 25.5 (20.5) | 23.5 (24.8) | 0.53 | 23.9 (23.7) | 21.1 (26.7) | 33.3 (24.0) |
| Social functioning | 12.8 (11.6) | 7.9 (13.6) | 0.08 | 8.8 (16.0) | 7.1 (11.7) | 5.6 (7.9) |
| Embarrassment | 11.5 (20.0) | 6.5 (13.4) | 0.15 | 6.7 (13.7) | 4.6 (9.6) | 16.7 (28.9) |
| Emotional health | 22.2 (19.8) | 16.1 (21.9) | 0.17 | 17.8 (22.9) | 14.2 (22.5) | 16.7 (7.9) |
UDI, DDI, IIQ data presented as mean (standard deviation)
Scores range between 0 (least bother) and 100 (maximum bother)